Cargando…
Commentary: An In Silico – In Vitro Pipeline Identifying an HLA-A*02:01(+) KRAS G12V(+) Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients
Autor principal: | Beer, Ilan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315040/ https://www.ncbi.nlm.nih.gov/pubmed/34326832 http://dx.doi.org/10.3389/fimmu.2021.523906 |
Ejemplares similares
-
Response: Commentary: An In Silico–In Vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients
por: Mishto, Michele, et al.
Publicado: (2021) -
An in silico—in vitro Pipeline Identifying an HLA-A(*)02:01(+) KRAS G12V(+) Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients
por: Mishto, Michele, et al.
Publicado: (2019) -
HLA-A*11:01:01:01, HLA-C*12:02:02:01-HLA-B*52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure
por: Khor, Seik-Soon, et al.
Publicado: (2021) -
HLA-DRB1*07:01–HLA-DQA1*02:01–HLA-DQB1*02:02 haplotype is associated with a high risk of asparaginase hypersensitivity in acute lymphoblastic leukemia
por: Kutszegi, Nóra, et al.
Publicado: (2017) -
Understanding CD8(+) T-cell responses toward the native and alternate HLA-A*02:01-restricted WT1 epitope
por: Nguyen, Thi HO, et al.
Publicado: (2017)